METHODS : Fifty-two patients with fasting glucose 100-240 mg/dL or glycosylated hemoglobin ( HbA1c ) > = 6.0 % and alanine aminotransferase ( ALT ) 40-250 IU/L were randomized to receive metformin ( 250 mg t.i.d. ) , or metformin ( 250 mg t.i.d. ) and carnitine -orotate complex ( 300 mg t.i.d. ) for 12 weeks ( n = 26 per group ) .